Cargando…
The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O(2)max Depends on the Severity of Arterial Hypoxemia
Treatment with recombinant human erythropoietin (rhEpo) induces a rise in blood oxygen-carrying capacity (CaO(2)) that unequivocally enhances maximal oxygen uptake (V̇O(2)max) during exercise in normoxia, but not when exercise is carried out in severe acute hypoxia. This implies that there should be...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500186/ https://www.ncbi.nlm.nih.gov/pubmed/18714372 http://dx.doi.org/10.1371/journal.pone.0002996 |